These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 23255089

  • 1. Expression of estrogen receptor, progesterone receptor, and Her-2/ neu in primary and extra-corporeal endometrial cancer.
    Tangjitgamol S, Tanvanich S, Srijaipracharoen S, Manusirivithaya S.
    Histol Histopathol; 2013 Jun; 28(6):787-94. PubMed ID: 23255089
    [Abstract] [Full Text] [Related]

  • 2. Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study.
    Srijaipracharoen S, Tangjitgamol S, Tanvanich S, Manusirivithaya S, Khunnarong J, Thavaramara T, Leelahakorn S, Pataradool K.
    Asian Pac J Cancer Prev; 2010 Jun; 11(1):215-20. PubMed ID: 20593959
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J, Talve L, Carpén O, Edqvist PH, Pontén F, Grénman S, Auranen A.
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [Abstract] [Full Text] [Related]

  • 4. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.
    Asian Pac J Cancer Prev; 2008 Sep; 9(4):553-6. PubMed ID: 19256737
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
    Halperin R, Zehavi S, Habler L, Hadas E, Bukovsky I, Schneider D.
    Eur J Gynaecol Oncol; 2001 Sep; 22(2):122-6. PubMed ID: 11446475
    [Abstract] [Full Text] [Related]

  • 6. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J, Filas V, Buszkiewicz E, Trzeciak P, Wojciechowski M, Koktysz R, Staniszewski W, Breborowicz J, Rojo MG.
    Folia Histochem Cytobiol; 2010 Jan 01; 48(1):19-25. PubMed ID: 20529811
    [Abstract] [Full Text] [Related]

  • 7. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY, Xu WZ, Wang Y, Shen DH, Wang JL, Wei LH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct 18; 43(5):743-8. PubMed ID: 22008688
    [Abstract] [Full Text] [Related]

  • 8. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
    Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC.
    Anticancer Res; 2005 Oct 18; 25(4):2921-7. PubMed ID: 16080545
    [Abstract] [Full Text] [Related]

  • 9. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.
    Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, Spina D, Bellan C, Lazzi S, Kostopoulos I, Luzi P, Leoncini L.
    Anal Quant Cytol Histol; 2006 Apr 18; 28(2):97-103. PubMed ID: 16637512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Correlation between receptor status and results of treatment in endometrial carcinoma].
    Baĭnazarova AA, Iskakova ZhK.
    Vopr Onkol; 2006 Apr 18; 52(6):654-8. PubMed ID: 17338243
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov 18; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 13. [The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer].
    Gottwald L, Kubiak R, Pasz-Walczak G, Sek P, Piekarski J, Szwalski J, Spych M, Chałubińska-Fendler J, Suzin J, Tyliński W, Jeziorski A.
    Ginekol Pol; 2013 Feb 18; 84(2):95-101. PubMed ID: 23668054
    [Abstract] [Full Text] [Related]

  • 14. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 18; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.
    Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D.
    Int J Gynecol Cancer; 2003 Feb 18; 13(1):32-7. PubMed ID: 12631217
    [Abstract] [Full Text] [Related]

  • 16. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
    Rahman MT, Nakayama K, Ishikawa M, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Miyazaki K.
    Oncology; 2013 Feb 18; 84(3):166-73. PubMed ID: 23306391
    [Abstract] [Full Text] [Related]

  • 17. Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India.
    Zubeda S, Kaipa PR, Shaik NA, Mohiuddin MK, Vaidya S, Pavani B, Srinivasulu M, Latha MM, Hasan Q.
    Asian Pac J Cancer Prev; 2013 Feb 18; 14(4):2231-5. PubMed ID: 23725118
    [Abstract] [Full Text] [Related]

  • 18. [Effectiveness of tissue microarray technique for the assessment of estrogen and progesterone receptors expression in endometrioid endometrial cancer--preliminary report].
    Gottwald L, Sek P, Kubiak R, Pasz-Walczak G, Piekarski J, Szwalski J, Suzin J, Tyliński W, Hendzel K, Jeziorski A.
    Ginekol Pol; 2012 May 18; 83(5):342-6. PubMed ID: 22708330
    [Abstract] [Full Text] [Related]

  • 19. Comparison of estrogen receptors, progesterone receptors and HER-2/neu expression between primary and metastatic breast carcinoma.
    Azam M, Qureshi A, Mansoor S.
    J Pak Med Assoc; 2009 Nov 18; 59(11):736-40. PubMed ID: 20361669
    [Abstract] [Full Text] [Related]

  • 20. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):142-53. PubMed ID: 12529347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.